For a long time Helicobacter pylori infections have been treated using the macrolide
antibiotic, clarithromycin. Clarithromycin resistance is increasing worldwide and is the most …

Conventional triple therapies for Helicobacter pylori (H. pylori) eradication have recently
shown a disappointing reduction in effectiveness in many countries. The main reason for …

Introduction Primary clarithromycin resistance is increasing worldwide, and it has been
regarded as the main factor reducing the efficacy of Helicobacter pylori therapy. However …

Objectives The frequency of primary clarithromycin resistance in Helicobacter pylori strains
is increasing worldwide, and its presence significantly reduces the treatment efficacy of …

A large survey of antimicrobial resistance of Helicobacter pylori was performed in France in
2014: 984 patients were enrolled by 75 gastroenterologists all over the country. Among the …

Objectives Resistance to clarithromycin is the most important factor causing failure of
Helicobacter pylori eradication. Although clarithromycin resistance is mainly associated with …

Objectives: We evaluated a new approach for the rapid detection of clarithromycin
resistance in Helicobacter pylori, based on PCR and denaturing HPLC (DHPLC). Methods …

Background. Helicobacter pylori (H. pylori) resistance to clarithromycin is increasing
worldwide. Data on the prevalence of H. pylori resistance are limited in Tunisia. Gap …

Background. Primary clarithromycin resistance markedly reduces Helicobacter pylori
eradication rate following standard therapies. Prevalence of primary clarithromycin …

Primary clarithromycin resistance is the main factor affecting the efficacy of Helicobacter
pylori therapy. This study aimed:(i) to assess the concordance between phenotypic (culture) …